NOW
APPROVED
in Adults with
PRURIGO
NODULARIS (PN)
DUPIXENT is
a prescription
medicine used to
treat adults with
prurigo nodularis
(PN). It is not
known if DUPIXENT
is safe and
effective in children
with prurigo
nodularis under
18 years of age.
DUPIXENT can help
control a source
of unwanted
inflammation
which could be a
driver of your PN
Proven results*
~3x as many adults
had significantly
less itch at 24
weeks
(In trial 1, 60% on DUPIXENT
vs 18.4% on placebo; in trial 2, 57.7%
on DUPIXENT vs 19.5% on placebo)
Some adults had
less itch in as
little as 12 weeks
(In trial 2, 37.2% on DUPIXENT vs 22%
on placebo)
~3x as many
adults had skin
that's clear or
almost clear
of PN bumps at
24 weeks
(In trial 1, 48% on DUPIXENT vs 18.4%
on placebo; in trial 2, 44.9% on DUPIXENT
vs 15.9% on placebo)
The most common
side effects in patients
with prurigo nodularis
include eye and eyelid
inflammation, including
redness, swelling, and
itching, sometimes with
blurred vision, herpes
virus infections,
common cold
symptoms
(nasopharyngitis),
dizziness, muscle pain,
and diarrhea.
NOW FDA
APPROVED